drugset / Trial / NCT04837703

Managed Access Programs for ETB115, Eltrombopag

NCT04837703

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to ETB115, Eltrombopag

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Eltrombopag Small molecule

Indications